Caribou Biosciences, Inc.
CRBU
$1.86
$0.105.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -157.13M | -164.26M | -147.86M | -149.11M | -148.12M |
| Total Depreciation and Amortization | 4.15M | 4.69M | 4.38M | 3.93M | 3.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.00M | 34.52M | 11.52M | 12.09M | 16.32M |
| Change in Net Operating Assets | -6.65M | -8.07M | -5.76M | -5.11M | 4.21M |
| Cash from Operations | -125.64M | -133.11M | -137.72M | -138.20M | -124.11M |
| Capital Expenditure | -2.09M | -2.65M | -4.47M | -4.88M | -6.64M |
| Sale of Property, Plant, and Equipment | 13.00K | 13.00K | 13.00K | 13.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.28M | 118.51M | 117.49M | 91.47M | 45.84M |
| Cash from Investing | 100.20M | 115.87M | 113.03M | 86.61M | 39.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.61M | 4.58M | 4.71M | 16.72M | 12.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.61M | 4.58M | 4.71M | 16.72M | 12.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.83M | -12.67M | -19.98M | -34.87M | -72.09M |